Annette Wright, BSN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 914 Duncan Ave, Yeadon, PA 19050 Phone: 610-517-5494 |
Mr. Mohamed Deen Yansane, BSN RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1027 Serrill Ave, Yeadon, PA 19050 Phone: 484-469-4692 Fax: 484-469-4694 |
Wade Duncan, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 832 Whitby Ave, Yeadon, PA 19050 Phone: 610-931-5367 |
Secret Lincoln, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 204 Macdade Blvd, Yeadon, PA 19050 Phone: 484-469-3787 Fax: 484-462-3974 |
Miss Allysha Tawana Smith, RN Registered Nurse - Home Health Medicare: Not Enrolled in Medicare Practice Location: 204 Macdade Blvd, Yeadon, PA 19050 Phone: 484-469-3787 |
Tara Nicole Hardy, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 844 W Cobbs Creek Pkwy, Yeadon, PA 19050 Phone: 610-500-4222 |
Mrs. Eunice Asibey, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1027 Serrill Ave, Yeadon, PA 19050 Phone: 484-469-4692 Fax: 484-469-4694 |
News Archive
A research group led by Professor Yasuko Mori (Division of Clinical Virology, Center for Infectious Diseases, Kobe University) have succeeded in humanization of mouse antibodies that can neutralize the infection caused by human herpesvirus 6B.
Researchers at the University of Michigan have described a new approach to discovering potential cancer treatments that requires a fraction of the time needed for more traditional methods.
A study on the effect of different alcoholic beverages and drinking behaviour on the risk of acute pancreatitis was conducted, using the Swedish Mammography Cohort and Cohort of Swedish Men, to study the association between consumption of spirits, wine and beer and the risk of acute pancreatitis.
People with addictions to stimulants tend to choose instant gratification or a smaller but sooner reward over a future benefit, even if the future reward is greater. Reduced value of a future reward, called "delay discounting" by neuroscientists, is the major challenge for treatment of addiction. A new study in the February 2011 (Vol. 69, Issue 3) Biological Psychiatry appears to present a strategy for increasing the value of future rewards in the minds of addicts.
A phase II study comparing first-line combination pazopanib/pemetrexed chemotherapy with the standard cisplatin/pemetrexed treatment in non-small-cell lung cancer was terminated early owing to an increased frequency of adverse events in the experimental arm.
› Verified 4 days ago